TargetAngiotensin-converting enzyme(Rattus norvegicus)
Research And Development Laboratories
Curated by ChEMBL
Research And Development Laboratories
Curated by ChEMBL
Affinity DataIC50: 0.510nMAssay Description:Compound was tested for inhibitory activity against angiotensin I converting enzymeMore data for this Ligand-Target Pair
TargetAngiotensin-converting enzyme(Rattus norvegicus)
Research And Development Laboratories
Curated by ChEMBL
Research And Development Laboratories
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Compound was tested for inhibitory activity against angiotensin I converting enzymeMore data for this Ligand-Target Pair
TargetAngiotensin-converting enzyme(Rattus norvegicus)
Research And Development Laboratories
Curated by ChEMBL
Research And Development Laboratories
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Compound was tested for inhibitory activity against angiotensin I converting enzymeMore data for this Ligand-Target Pair
TargetAngiotensin-converting enzyme(Rattus norvegicus)
Research And Development Laboratories
Curated by ChEMBL
Research And Development Laboratories
Curated by ChEMBL
Affinity DataIC50: 0.950nMAssay Description:Compound was tested for inhibitory activity against angiotensin I converting enzymeMore data for this Ligand-Target Pair
TargetAngiotensin-converting enzyme(Rattus norvegicus)
Research And Development Laboratories
Curated by ChEMBL
Research And Development Laboratories
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Compound was tested for inhibitory activity against angiotensin I converting enzymeMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Compound was tested for in vitro activity against s-phospholipase A2 (s-PLA2) isolated from human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:In vitro inhibition of porcine pancreatic phospholipase A2 evaluated by monomeric substrate assayMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:In vitro inhibition of porcine pancreatic phospholipase A2 evaluated by monomeric substrate assayMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Compound was tested for in vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and micellar substrate with deoxycholate (DOC)More data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
Affinity DataIC50: 65nMAssay Description:Compound was tested for in vitro activity against s-phospholipase A2 (s-PLA2) isolated from human plateletsMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 95nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and micellar substrate with deoxycholate (DOC)More data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 230nMAssay Description:In vitro inhibition of porcine pancreatic phospholipase A2 evaluated by Deoxycholate-phospholipid mixed micelle assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 380nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and micellar substrate with deoxycholate (DOC)More data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 410nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair